CASI Pharmaceuticals, Inc.
CASI
$1.94
$0.22713.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -47.70% | -41.53% | -67.19% | -55.60% | -40.06% |
| Total Receivables | 51.36% | -4.40% | -38.19% | -45.39% | -21.85% |
| Inventory | -66.92% | 46.38% | 88.16% | 80.04% | 158.67% |
| Prepaid Expenses | 12.81% | 11.60% | 10.29% | -23.86% | -13.95% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -33.31% | -18.87% | -39.03% | -35.20% | -19.18% |
|
|
|||||
| Total Current Assets | -33.31% | -18.87% | -39.03% | -35.20% | -19.18% |
| Net Property, Plant & Equipment | -2.35% | 16.80% | -10.77% | -12.60% | -12.06% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -87.06% | 309.16% | 152.89% | 100.00% | 73.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -23.37% | -56.53% | -42.67% | -38.74% | -27.46% |
| Total Assets | -28.69% | -14.30% | -34.16% | -34.37% | -21.79% |
|
|
|||||
| Total Accounts Payable | -38.64% | -31.17% | -66.64% | -79.36% | 34.93% |
| Total Accrued Expenses | 18.47% | 40.06% | -56.88% | -24.41% | -6.45% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2,593.13% | -- | -- | -- | -16.13% |
| Total Finance Division Other Current Liabilities | 28.16% | -- | -- | -- | -15.26% |
| Total Other Current Liabilities | 28.16% | -- | -- | -- | -15.26% |
| Total Current Liabilities | 117.94% | 24.62% | -19.52% | -39.13% | -1.64% |
|
|
|||||
| Total Current Liabilities | 117.94% | 24.62% | -19.52% | -39.13% | -1.64% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 56.87% | -- | -- | -- | 239.50% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -7.43% | 32.92% | 5.75% | 27.02% | 17.30% |
| Total Liabilities | 1.41% | 109.17% | 75.81% | 62.56% | 74.40% |
|
|
|||||
| Common Stock & APIC | 2.52% | 2.43% | 0.60% | 0.64% | 0.58% |
| Retained Earnings | -5.94% | -4.58% | -3.91% | -4.36% | -3.71% |
| Treasury Stock & Other | -5.31% | -16.25% | -16.48% | -4.81% | -7.68% |
| Total Common Equity | -92.34% | -51.91% | -72.01% | -60.92% | -45.79% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -92.34% | -51.91% | -72.01% | -60.92% | -45.79% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -92.34% | -72.54% | -83.25% | -75.14% | -63.90% |
|
|
|||||